background image

Paid Clinical Trials Toledo

Discover 757 paid clinical trials in Toledo, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2
Active & Responsive

Phase 2 Study of Inhaled SNG001 in Mechanically Ventilated Patients With Respiratory Viral Infection

for
Viral Pneumonia
Location: Toledo OH, Detroit MI, Royal Oak MI, Columbus OH,
Sponsor: Synairgen Research Ltd.

Sex: All

Age: 18+

Code: NCT06999603

Phase2, Recruiting
Active & Responsive

Clinical Utility of Management of Patients With Pulmonary Nodules Using the Percepta Nasal Swab Classifier

for
Pulmonary Nodule, Solitary, Lung Cancer
Location: Toledo OH, Cincinnati OH, Chicago IL, Lexington KY,
Sponsor: Veracyte, Inc.

Sex: All

Age: 29 - 70+

Code: NCT06426628

Recruiting
Active & Responsive

Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Toledo OH, Maumee OH, Monroe MI, Adrian MI,
Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT05929768

Phase3, Recruiting
Active & Responsive

Phase 2 Study to Assess the Safety and Efficacy of ANG003

for
Exocrine Pancreatic Insufficiency (EPI), Cystic Fibrosis (CF)
Location: Toledo OH, Ann Arbor MI, Akron OH, Glenview IL,
Sponsor: Anagram Therapeutics, Inc.

Sex: All

Age: 12+

Code: NCT07450547

Phase2, Recruiting
Active & Responsive

A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphosphatemia

for
Hyperphosphatemia,
Location: Toledo OH, Shelby MI, Dalton GA, Ridgewood NY,
Sponsor: R1 Therapeutics

Sex: All

Age: 18+

Code: NCT06712654

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image
Active & Responsive

Tempus CRC Surveillance Study: A ctDNA Biomarker Profiling Study of Patients With CRC Using NGS Assays

for
Colorectal Cancer
Location: Toledo OH, Columbus OH, Canton OH, Cincinnati OH,
Sponsor: Tempus AI

Sex: All

Age: 18+

Code: NCT05234177

Recruiting
Active & Responsive

Efficacy & Safety of Olvi-Vec and Platinum-doublet + Bevacizumab Compared to Physician's Choice of Chemotherapy and Bevacizumab in Platinum-Resistant/Refractory Ovarian Cancer (PRROC) (OnPrime, GOG-3076)

for
Platinum-resistant Ovarian Cancer,
Location: Sylvania OH, Ann Arbor MI, Detroit MI, Cleveland OH,
Sponsor: Genelux Corporation

Sex: Female

Age: 18+

Code: NCT05281471

Phase3, Recruiting
Active & Responsive

Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma

for
Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC,
Location: Maumee OH, Chicago IL, Arlington Heights IL, Peoria IL,
Sponsor: Immuneering Corporation

Sex: All

Age: 18+

Code: NCT07562152

Phase3, Recruiting
Active & Responsive

Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors

for
Solid Tumor Malignancies, Colorectal Carcinoma,
Location: Maumee OH, Cleveland OH, Grand Rapids MI, Fairfax VA,
Sponsor: Tasca Therapeutics

Sex: All

Age: 18+

Code: NCT07030257

Phase1, Phase2, Recruiting
Active & Responsive

VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma

for
Head and Neck Carcinoma, Adenoid Cystic Carcinoma, Lung Cancer,
Location: Maumee OH, York PA, Washington D.C. DC, Morristown NJ,
Sponsor: VM Oncology, LLC

Sex: All

Age: 18 - 70+

Code: NCT03556228

Phase1, Phase2, Recruiting